A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
Recruiting
Phase 1
Interventional Study
Healthy Volunteers
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 104 (estimated)
- Sponsor
- argenx · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to assess the safety of ARGX-124 in healthy adults. Another aim is to measure the amount of ARGX-124 in the blood over time to learn how it acts and moves in the body and how the immune system responds to it. Participants will remain in the study for up to approximately 23 weeks.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Is at least the local legal age of consent and aged 18 to 65 years, inclusive, when signing the ICF.
* Is a female of Nonchildbearing Potential (postmenopausal or surgically sterilized) or a male.
* Has a body weight between 50 and 120 kg and a BMI between 18 and 30.5 kg/m2, i…
Contacts